Coronavirus mutations in New York, California cause concern | Science | In-depth Science and Technology Reports | DW



[ad_1]

Since health authorities began to more carefully sequence COVID-19 positive cases – that is, to genetically examine test results – they have also found more and more mutations.

Most of these mutations are insignificant. But there are a few variations that worry researchers and officials, in part because they are more contagious and because existing vaccines might be less effective at protecting against them.

A border checkpoint on the Czech-German border

More freedom of movement. Some countries are trying to stem the spread of mutations by closing borders.

In addition to the variants identified in Britain, South Africa and Brazil, there are two other worrisome variants in the United States that appear to have evolved there.

Rapid spread

In November, researchers first noticed a mutation in New York called B.1.526. Since then, this variant has spread rapidly throughout the metropolis and throughout the state. As of mid-February, it had been detected in 12% of all New York samples that had been sequenced by genes.

This variant has also appeared in other countries such as Denmark.

Woman wearing face mask jogs in front of Golden Gate Bridge background

The California variant, CAL.20, is believed to be more contagious than the original virus, but not as dangerous as the UK variant.

The so-called California variant, first detected in July 2020, has also spread rapidly. Meanwhile, the two similar types, B.1.427 and B.1.429, of the California variant can be found in about a quarter of the samples sequenced by genes in California.

What do we know about the two American variants?

So far, we do not have reliable and complete data on these variants. The California variant, CAL.20C, is believed to be more contagious than the original SARS-CoV-2 virus. In swabs taken from infected individuals, the viral load of the samples was found to be approximately doubled. But it is less contagious than the British mutant B.1.1.7, which has now been detected in a large number of countries, including Germany. Existing vaccines are believed to be somewhat less effective against the California virus variant, but still sufficient to protect patients from a severe course of COVID-19.

The variant of New York virus, B.1.526, is similar to the South African variant, B.1.351, which has already been detected in more than 40 countries, and also bears similarity to the Brazilian variants, P.1 and P.2, which have been detected in over 20 countries, most recently in the UK.

It is still unclear whether the New York variant is more contagious or dangerous, and whether existing vaccines are still sufficiently effective against this variant.

New software helps research

Finding the respective variants is only possible if you know what to look for. Although we now know the genome of SARS-CoV-2, the virus is 29,903 nucleotides in length, which is far too long to allow rapid identification of variants that could make it more infectious among the 611,000 genomes now stored in the GISAID database.

The mutations were found using new software called Variant Database (VDB) developed at the California Institute of Technology in Pasadena, by a team led by Pamela Bjorkman. It focuses on the changes in the spike protein.

A man passes a swab in Johannesburg

A mutation called E484K has been found in the South African and Brazilian variant.

The potentially dangerous mutation E484K, which is present in B.1.351 and P.1, alters the receptor binding domain of the spike protein, and this is where the antibodies with the strongest neutralizing effect attack.

A source of worry, but no panic

The tip of the spike protein is also modified in the New York variant. Naturally, this raised concerns, epidemiologist Wafaa El-Sadr of Columbia University told German public broadcaster ARD. “These changes may allow the spike protein to bind better. Or that the virus may reproduce faster. Or that it cannot be fought off by antibodies through our vaccines,” he said.

But, until detailed and solid data on the US variants becomes available, these observations remain speculative and there is no need to panic, said Dave Chokshi, commissioner in the Department of Health and Hygiene. mental health of New York City. So far, there is no evidence that it is spreading any faster, either to make people sicker or to reduce the effectiveness of the vaccine, he said.

This article has been translated from German.



[ad_2]

Source link